FLORHAM PARK, N.J.--(BUSINESS WIRE)--Whatman plc, a global leader in separations and protein array technology, today announced that its multiplex protein biochip, branded CombiChip(R), has received CE Registration for the detection of autoimmune diseases. This novel assay system was developed in a partnership with Privates Institut fur Immunologie und Molekulargenetik GmbH (IIM), a premier German laboratory that specializes in autoimmune and other clinical diagnostic assays. Whatman/Schleicher & Schuell plans to make the CombiChip available to reference laboratories as a CE-marked in-vitro diagnostic kit.
